ProfileGDS4718 / 234236_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 13% 11% 16% 15% 13% 13% 19% 7% 16% 13% 5% 7% 14% 9% 15% 12% 14% 11% 4% 20% 14% 14% 9% 13% 10% 7% 11% 14% 10% 8% 11% 18% 10% 6% 6% 12% 11% 13% 12% 22% 10% 5% 12% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9695415
GSM549102patient 115, normal, homogenized [OPG study]3.8869713
GSM549104patient 119, normal, homogenized [OPG study]3.7818311
GSM549108patient 138, normal, homogenized [OPG study]4.0468916
GSM549119patient 077, normal, homogenized [OPG study]3.9570615
GSM549133patient 032, cancer, homogenized [OPG study]3.8581313
GSM549139patient 042, cancer, homogenized [OPG study]3.8610713
GSM549099patient 107, normal, homogenized [OPG study]4.1123219
GSM549109patient 139, normal, homogenized [OPG study]3.687987
GSM549110patient 046, normal, homogenized [OPG study]4.0096516
GSM549114patient 063, normal, homogenized [OPG study]3.8717913
GSM549122patient 082, normal, homogenized [OPG study]3.585395
GSM549134patient 033, cancer, homogenized [OPG study]3.660647
GSM549136patient 036, cancer, homogenized [OPG study]3.882914
GSM549140patient 044, cancer, homogenized [OPG study]3.713199
GSM549111patient 047, normal, homogenized [OPG study]3.9326115
GSM549113patient 057, normal, homogenized [OPG study]3.8267412
GSM549132patient 031, cancer, homogenized [OPG study]3.9200314
GSM549137patient 038, cancer, homogenized [OPG study]3.7980911
GSM549142patient 047, cancer, homogenized [OPG study]3.548994
GSM549100patient 110, normal, homogenized [OPG study]4.1577420
GSM549107patient 135, normal, homogenized [OPG study]3.9041514
GSM549115patient 068, normal, homogenized [OPG study]3.8880114
GSM549116patient 072, normal, homogenized [OPG study]3.73979
GSM549120patient 078, normal, homogenized [OPG study]3.8990913
GSM549131patient 030, cancer, homogenized [OPG study]3.7454710
GSM549118patient 074, normal, homogenized [OPG study]3.662327
GSM549129patient 027, cancer, homogenized [OPG study]3.8284811
GSM549123patient 088, normal, homogenized [OPG study]3.9346314
GSM549124patient 006, cancer, homogenized [OPG study]3.7901410
GSM549126patient 015, cancer, homogenized [OPG study]3.667378
GSM549128patient 025, cancer, homogenized [OPG study]3.7861111
GSM549103patient 117, normal, homogenized [OPG study]4.1129818
GSM549117patient 073, normal, homogenized [OPG study]3.7797210
GSM549138patient 041, cancer, homogenized [OPG study]3.617366
GSM549141patient 045, cancer, homogenized [OPG study]3.56466
GSM549130patient 028, cancer, homogenized [OPG study]3.8692312
GSM549101patient 111, normal, homogenized [OPG study]3.7992811
GSM549105patient 128, normal, homogenized [OPG study]3.9148213
GSM549106patient 134, normal, homogenized [OPG study]3.8142512
GSM549112patient 048, normal, homogenized [OPG study]4.2230122
GSM549125patient 011, cancer, homogenized [OPG study]3.7911410
GSM549127patient 024, cancer, homogenized [OPG study]3.562125
GSM549135patient 035, cancer, homogenized [OPG study]3.8023712